Position in CPRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$6,853,023
-$1,169,798 QoQ
Shares Held
276,778
-19.5% QoQ
Ownership
0.226%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in CPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FMR LLC holds $49,682,018,247 across 354 Biotechnology names. CPRX ranks #158 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
14,579,166 | $4,823,808,652 | |
| 2 | ARGX |
Argenx SE
|
4,991,034 | $3,644,702,577 | |
| 3 | MRNA |
Moderna, Inc.
|
45,672,024 | $2,320,138,818 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
77,981,253 | $2,160,080,705 | |
| 5 | INSM |
INSMED Inc
|
13,160,167 | $2,151,950,504 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,556,637 | $1,843,957,869 | |
| 7 | RPRX |
Royalty Pharma plc
|
25,152,242 | $1,206,553,046 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,518,192 | $1,173,015,865 |
All Filings in CPRX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,853,023 | 276,778 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $8,022,821 | 343,737 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $7,135,674 | 362,217 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $11,047,751 | 509,113 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $7,757,065 | 319,879 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $2,347,498 | 112,482 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,959,769 | 98,580 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,228,511 | 79,310 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,176,849 | 73,830 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $217,252 | 12,924 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $362,751 | 31,031 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $979,292 | 72,864 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $262,709 | 15,845 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $289,117 | 15,544 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $544,620 | 42,449 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $29,567 | 4,218 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $28,151 | 3,396 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $13,668 | 2,019 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $12,820 | 2,419 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $6,629 | 1,153 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $8,298 | 1,800 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $6,012 | 1,800 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $5,346 | 1,800 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $3,316 | 718 | Shares | Defined | 2020-08-24 | |
| 2020-03-31 | $550 | 143 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||